Literature DB >> 6153593

Central monoamine metabolism in depressions. I. Serotonin and related compounds.

H M van Praag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6153593     DOI： 10.1016/0010-440x(80)90062-0

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN： 0010-440X            Impact factor:   3.735


× No keyword cloud information.
  9 in total

1.  Enhancement of imipramine-induced rat brain beta-adrenoreceptor desensitization by subacute co-administration of trazodone, zimelidine, quipazine or 5-hydroxytryptophan.

Authors:  A A Alhaider; A A Mustafa
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Neurotransmitters in CSF of idiopathic adult-onset dystonia: reduced 5-HIAA levels as evidence of impaired serotonergic metabolism.

Authors:  M Naumann; M Götz; K Reiners; K W Lange; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Personality factors predisposing to depression correlate significantly negatively with M1-muscarinic and beta-adrenergic receptor densities on blood cells.

Authors:  H W Moises; B Bering; W E Müller
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

4.  Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence.

Authors:  C M Banki
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

5.  Central serotonin receptors and delayed gastric emptying in non-ulcer dyspepsia.

Authors:  A Chua; J Keating; D Hamilton; P W Keeling; T G Dinan
Journal:  BMJ       Date:  1992-08-01

6.  Platelets and biogenic amines. 1. Platelets are poor investigative models for dopamine re-uptake.

Authors:  R Malmgren
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Prolactin, amitriptyline, and recovery from depression.

Authors:  J Lisansky; G A Fava; M T Buckman; R Kellner; M Fava; M Zielezny; G T Peake
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Controlled comparison of milnacipran and fluoxetine in major depression.

Authors:  M Ansseau; P Papart; B Troisfontaines; F Bartholomé; M Bataille; G Charles; M Schittecatte; P Darimont; J M Devoitille; J De Wilde
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

9.  Role of cholecystokinin and central serotonergic receptors in functional dyspepsia.

Authors:  Andrew Seng Boon Chua; P W N Keeling; T G Dinan
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.